Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Guadix SW, Marianayagam NJ, Weidman EK, Yuan M, Liechty B, Greenfield JP, et al. Defining Occult High-Risk Cysts of the Pineal Region: A Case Series. Oper Neurosurg (Hagerstown). 2023;24(6):572-581.

Mularoni V, Donati B, Tameni A, Manicardi V, Reggiani F, Sauta E, et al. Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma. Haematologica. 2023;108(12):3333-3346.

Hongo JA, de Castro GM, Menezes AP, Picorelli AC, da Silva TT, Imada EL, et al. CALANGO: A phylogeny-aware comparative genomics tool for discovering quantitative genotype-phenotype associations across species. Patterns (N Y). 2023;4(6):100728.

Rozental O, Cushing MM, Shander A, Isbister JP, Lasocki S, Meybohm P, et al. Penny-wise and pound-foolish: the challenges of preoperative anaemia management. Br J Anaesth. 2023;131(2):214-221.

Maura F, Ziccheddu B, Xiang JZ, Bhinder B, Rosiene J, Abascal F, et al. Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells. Blood Cancer Discov. 2023;4(3):208-227.

Galassi C, Klapp V, Formenti SC, Demaria S, Galluzzi L. Immunologically relevant effects of radiation therapy on the tumor microenvironment. Essays Biochem. 2023.

Saoud C, Lam H, Ali SZ. Fine-Needle Aspiration of Sarcomas Metastatic to Lymph Nodes: A Cytomorphologic Study over a 10-Year Period. Acta Cytol. 2023;67(5):493-506.

Helfgott DC, Racine-Brzostek S, Short KJ, Zhao Z, Christos P, Nino I, et al. Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome. Leuk Lymphoma. 2023;64(3):662-670.

Mukhopadhyay C, Zhou P. Role(s) of G3BPs in Human Pathogenesis. J Pharmacol Exp Ther. 2023;387(1):100-110.

Gomez-Arteaga A, Orfali N, Pasciolla M, Baptiste A, Guindine I, Hsu JM, et al. Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone Marrow Transplant. 2023;58(7):835-838.